コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 atelet aggregation was measured by impedance aggregometry.
2 luding flow cytometry and light transmission aggregometry.
3 Platelet function was measured by aggregometry.
4 with VerifyNow-P2Y12 and light transmission aggregometry.
5 VerifyNow-P2Y12, but not light transmission aggregometry.
6 s differences in IC(5)(0) values obtained by aggregometry.
7 nders were identified by light transmittance aggregometry.
8 gation at 6 h assessed by light-transmission aggregometry.
9 ns and measured response by ex vivo platelet aggregometry.
10 eline and steady state by light-transmission aggregometry.
11 ggregation (PA) was assessed by conventional aggregometry.
12 very of platelet function than turbidimetric aggregometry.
13 id, ADP, collagen, or epinephrine by optical aggregometry.
14 osine diphosphate-induced light transmission aggregometry (11.6% relative increase in maximal platele
15 gregation between groups (multiple electrode aggregometry, 17.6+/-7.2 versus 18.1+/-6 U; P=0.281).
16 2 reaction units [PRU]), light transmittance aggregometry (adenosine diphosphate 5 and 20 mumol/l and
18 imuli were assessed with light transmittance aggregometry and defined patients with high post-treatme
19 -deficient platelets were confirmed via lumi-aggregometry and FACS analysis for P-selectin and LAMP-1
20 elets, as determined by whole blood platelet aggregometry and flow cytometric analysis of the platele
25 gation was measured using multiple electrode aggregometry and standard light transmission aggregometr
26 ion than patients without ischemic events by aggregometry and TEG (p < 0.001 for both measurements).
27 treatment platelet reactivity as measured by aggregometry and TEG were the only variables significant
29 telet Analyzer (CPA), with in vitro platelet aggregometry and the Rapid Platelet Function Assay (RPFA
30 ion measured by standard light transmittance aggregometry and thrombelastography (TEG) will be at inc
31 latelet reactivity measured by turbidometric aggregometry and thrombin-induced platelet-fibrin clot s
32 tivation of platelets by CRP and collagen in aggregometry and thrombus formation by the latter in who
33 1 h, 4 h, and 24 h using light transmission aggregometry and vasodilator-stimulated phosphoprotein p
34 imulated phosphoprotein, light transmittance aggregometry, and Multiplate were similar between prasug
35 imulated phosphoprotein, light transmittance aggregometry, and Multiplate, which allowed us to explor
36 we have developed a miniaturized whole blood aggregometry assay, based on a readily accessible 96-wel
37 aggregation (20 muM) by light transmittance aggregometry at 1 week (primary end point) was lower aft
38 latelet reactivity was assessed by impedance aggregometry before loading (intrinsic platelet reactivi
39 nction was shown by flow cytometry, platelet aggregometry, bleeding assays, and intravital imaging of
41 tomic force microscopy (small contact zone), aggregometry (discrete interactions), micropipette manip
42 function was monitored with the CPA and with aggregometry for up to 1 week after abciximab administra
43 diphosphate was measured with turbidimetric aggregometry in both D-phenylalanyl-L-prolyl-L-arginine
44 optimization of older tests such as platelet aggregometry, in addition to better defining the role of
46 aggregometry and standard light transmission aggregometry just before the switch and at 2, 6, 24, and
47 ine diphosphate (ADP) by light transmittance aggregometry (LTA) in patients undergoing PCI (n = 192).
51 tery disease (CAD) using light transmittance aggregometry (LTA), VerifyNow, platelet function analyze
53 egation was measured with light transmission aggregometry (LTA); platelet activation was assessed by
55 were assessed by means of light transmission aggregometry of suspensions with varying ratios of plate
58 is more severe in LAD-III patients, classic aggregometry or perfusion of Glanzmann or LAD-III platel
60 ost-dose, as measured by light transmittance aggregometry or vasodilator-stimulated phosphoprotein as
61 NAC thrombolytic effect, including platelet aggregometry, platelet-rich thrombi lysis assays, thromb
66 ated platelet function assessed by classical aggregometry, single-particle counting, granule secretio
70 days, and 14 days using light transmittance aggregometry, VerifyNow P2Y(12) assay, and vasodilator-s
71 schemic risk measured by light transmittance aggregometry, VerifyNow P2Y(12) assay, and vasodilator-s
72 difference in measurements between RPFA and aggregometry was -4% (+/-4% SD), and the mean difference
75 results were found using light transmittance aggregometry with 5 muM adenosine diphosphate, VerifyNow
76 t fibrinogen binding, and light transmission aggregometry with ADP 5 and 10 mumol/l recorded at maxim
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。